Home

PMV Pharmaceuticals, Inc. (PMVP)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about PMV Pharmaceuticals, Inc. (PMVP)

Go deeper and ask any question about PMVP

Company Performance

Current Price

as of Sep 13, 2024

$1.51

P/E Ratio

N/A

Market Cap

$77.79M

Description

PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.

Metrics

Overview

  • HQPrinceton, NJ
  • SectorCommercial Services
  • IndustryMiscellaneous Commercial Services
  • TickerPMVP
  • Price$1.51+1.34%

Trading Information

  • Market Cap$77.79M
  • Float84.99%
  • Average Daily Volume (1m)195,191
  • Average Daily Volume (3m)338,611
  • EPS-$0.97

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$1.21M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$19.80M
  • EV-$117.35M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
Documents